Results 141 to 150 of about 8,311 (168)

[EVA1A overexpression improves non-alcoholic fatty liver disease in mice by regulating lipid metabolism and promoting lipophagy]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xu J, Yang D, Zang K, Chu M, Zhao Q, Li Q, Lu S, Chen X, Li N.   +8 more
europepmc   +1 more source

[Research progress in liver cancer in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Miao TG, Nan YM.
europepmc   +1 more source

[Advances in clinical features, diagnosis, and treatment of pre-acute-on-chronic liver failure]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Nie YH, Cai DC.
europepmc   +1 more source

[Gandou Bushen decoction ameliorates ovarian injury in murine hepatolenticular degeneration via the AGE/RAGE/NF-κB signaling pathway]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Jiang P, Wu L, Han H.
europepmc   +1 more source

[Analysis of urine biomarkers in urothelial carcinoma based on untargeted metabolomics]. [PDF]

Se Pu
Liu S, Wang M, Wang W.
europepmc   +1 more source

[Efficacy and safety of emergency administration of tranexamic acid in elderly patients with intertrochanteric femoral fractures]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Rui C, Dai G, Fan W, Zhou S, Tian C, Shi L, Xie T, Zhang C, Chen X, Chen H, Rui Y.   +10 more
europepmc   +1 more source

低分子肝素钙注射方法的改进

Huli yanjiu, 2004
李玲
doaj  

Some of the next articles are maybe not open access.

Related searches:

慢阻肺患者予以低分子肝素抗凝治疗对Xa活性、APTT与AT指标的影响

健康文摘
目的:探讨西宁地区慢阻肺患者予以低分子肝素抗凝治疗的效果。方法:选取2023年10月-2024年2月间收治患者26例,对其均实施低分子肝素抗凝治疗。对比用药前后抗Xa因子活性(Anti-Xa)、活化部分凝血活酶时间(APTT)与抗凝血酶(AT-Ⅲ)指标。结果:治疗前,Anti-Xa活性为(0.018±0.01)IU/ml,经治疗后,患者Xa活性水平达(0.18±0.11)IU/ml,APTT和AT无显著变化,P>0.05。结论:西宁地区慢阻肺患者应用低分子肝素抗凝治疗后,Anti ...
莹颖 赵
semanticscholar   +1 more source

低分子肝素对慢阻肺急性加重期炎性因子及血管内皮功能的影响

Medical Research and Practice
目的 探讨低分子肝素（LMWH）对慢阻肺急性加重期（AECOPD）患者炎性因子和血管内皮功能的影响。方法 从80例AECOPD 患者中随机分为对照组（n=40）和观察组（n=40），时间范围为2022年1月至2023年8月。对照组予以常规治疗（抗感染、平喘、祛痰等），观察组在常规治疗的基础上加用LMWH，疗程10 d。比较两组治疗前后mMRC、NLR、PLR、IL-6、TNF-α、ET-1及NO 的评分变化。结果 治疗后，观察组mMRC评分低于对照组，差异极显著（P < 0.001）。与对照组相比 ...
实 陈
semanticscholar   +1 more source